Drugs / Citrasate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01228292 | Jan 2011 → Jan 2012 | acute kidney injury | University Hospital, Antwerp | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Citrasate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01228292 ↗ |
| Known as | Citrasate, Advanced Renal Technologies, MA #K000792 | “Citrasate, Advanced Renal Technologies, MA #K000792” NCT01228292 ↗ |
| Action | Inhibit | “regional anticoagulation with Citrasate®” NCT01228292 ↗ |
| Route | Other | “Citrasate is infused as a dialysate” NCT01228292 ↗ |